BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38387708)

  • 41. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
    Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
    Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline Mutations in FAF1 Are Associated With Hereditary Colorectal Cancer.
    Bonjoch L; Franch-Expósito S; Garre P; Belhadj S; Muñoz J; Arnau-Collell C; Díaz-Gay M; Gratacós-Mulleras A; Raimondi G; Esteban-Jurado C; Soares de Lima Y; Herrera-Pariente C; Cuatrecasas M; Ocaña T; Castells A; Fillat C; Capellá G; Balaguer F; Caldés T; Valle L; Castellví-Bel S
    Gastroenterology; 2020 Jul; 159(1):227-240.e7. PubMed ID: 32179092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
    Terashima T; Morizane C; Ushiama M; Shiba S; Takahashi H; Ikeda M; Mizuno N; Tsuji K; Yasui K; Azemoto N; Satake H; Nomura S; Yachida S; Sugano K; Furuse J
    Jpn J Clin Oncol; 2022 Oct; 52(10):1105-1114. PubMed ID: 36135357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
    Shin HC; Lee HB; Yoo TK; Lee ES; Kim RN; Park B; Yoon KA; Park C; Lee ES; Moon HG; Noh DY; Kong SY; Han W
    Cancer Res Treat; 2020 Jul; 52(3):697-713. PubMed ID: 32019277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.
    Hoffman TL; Kershberg H; Goff J; Holmquist KJ; Haque R; Alvarado M
    Fam Cancer; 2023 Apr; 22(2):225-235. PubMed ID: 36261688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
    Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
    JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy.
    Paduano F; Colao E; Fabiani F; Rocca V; Dinatolo F; Dattola A; D'Antona L; Amato R; Trapasso F; Baudi F; Perrotti N; Iuliano R
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling.
    Ueki A; Sugano K; Misu K; Aimono E; Nakamura K; Tanishima S; Tanaka N; Mikami S; Hirasawa A; Ando M; Yoshida T; Oya M; Nishihara H; Kosaki K
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.
    Boulouard F; Kasper E; Buisine MP; Lienard G; Vasseur S; Manase S; Bahuau M; Barouk Simonet E; Bubien V; Coulet F; Cusin V; Dhooge M; Golmard L; Goussot V; Hamzaoui N; Lacaze E; Lejeune S; Mauillon J; Beaumont MP; Pinson S; Tlemsani C; Toulas C; Rey JM; Uhrhammer N; Bougeard G; Frebourg T; Houdayer C; Baert-Desurmont S
    Clin Genet; 2021 May; 99(5):662-672. PubMed ID: 33454955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Germline whole genome sequencing in adults with multiple primary tumors.
    Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
    Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis.
    Apellaniz-Ruiz M; Sabbaghian N; Chong AL; de Kock L; Cetinkaya S; Bayramoğlu E; Dinjens WNM; McCluggage WG; Wagner A; Yilmaz AA; Foulkes WD
    Fam Cancer; 2023 Oct; 22(4):487-493. PubMed ID: 37248399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
    Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
    Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
    Slavin TP; Coffee B; Bernhisel R; Logan J; Cox HC; Marcucci G; Weitzel J; Neuhausen SL; Mancini-DiNardo D
    Cancer Genet; 2019 Jun; 235-236():31-38. PubMed ID: 31056428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional Common and Rare
    Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K
    Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.